Dr. Erez Eitan to Participate in the Alzheimer’s Association International Conference (AAIC) 2024
We are thrilled to announce that Dr. Erez Eitan, NeuroDex’s chief scientific officer (CSO), will participate in the upcoming Alzheimer’s Association International Conference (AAIC) 2024. This prestigious event, taking place from July 28 to August 1 in Philadelphia, USA, will bring together leading scientists, researchers, and healthcare professionals from around the globe to discuss the latest advancements in Alzheimer’s research and treatment.
About AAIC
The Alzheimer’s Association International Conference is the world’s largest and most influential conference dedicated to advancing dementia science. AAIC provides a unique platform for exchanging innovative ideas and research findings that aim to improve the lives of those affected by Alzheimer’s disease and other dementias. With a diverse agenda that includes keynote presentations, workshops, and poster sessions, the conference fosters collaboration and knowledge sharing among professionals in the field.
Dr. Erez Eitan’s Contributions
Dr. Eitan’s work has significantly advanced our understanding of neurodegenerative diseases, particularly Alzheimer’s disease. As the CSO of NeuroDex, his research focuses on developing cutting-edge diagnostic tools and therapeutic strategies that leverage the power of exosomes and extracellular vesicles. At AAIC 2024, Dr. Eitan will present his latest findings and engage with other experts to discuss the implications of his research for the future of Alzheimer’s treatment.
Schedule a Meeting
We encourage attendees of AAIC 2024 to take advantage of this opportunity to connect with Dr. Eitan. Whether you are interested in discussing his research, exploring potential collaborations, or seeking insights into the latest developments in Alzheimer’s science, scheduling a meeting with Dr. Eitan can provide valuable perspectives.
To schedule a meeting with Dr. Eitan during the conference, please contact us at info@neurodex.co. We look forward to facilitating meaningful discussions and fostering collaborations that can drive progress in Alzheimer’s research.
Looking Forward
As we approach AAIC 2024, we remain committed to our mission of advancing the understanding and treatment of neurodegenerative diseases. Dr. Eitan’s participation in this conference underscores our dedication to staying at the forefront of scientific innovation and collaboration.
Stay tuned for more updates on Dr. Eitan’s presentations and insights from the conference. Together, we can make a difference in the fight against Alzheimer’s disease.
